J Cancer 2017; 8(12):2191-2204. doi:10.7150/jca.19128

Research Paper

Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreas

Yumei Guo1#, Junling Ren1#, Xiaoou Li2, Xiaofeng Liu2, Ning Liu3, Yanmin Wang4, Zhili Li1,✉

1. Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, PR China
2. Department of Laboratory, Tumor Hospital of Jilin Province, Changchun, PR China
3. Central Laboratory, Jilin University Second Hospital, Changchun, PR China
4. Department of Clinical Laboratory, Heze Municipal Hospital, Shandong, PR China
#Both authors contributed equally to this work.

Abstract

Background: Aberrant lipid metabolism is closely associated with cancer.

Materials & Methods: Serum levels of sphingomyelins (SM) (34:1), phosphatidylcholine (PC) (34:2), PC(34:1), PC(36:4), PC(36:3), and PC(36:2) in 1449 serum samples (including 599 normal controls, 69 patients with benign lung diseases (BLDs), 61 with benign colorectal diseases, 54 with benign gastric diseases, 67 with benign pancreatic diseases, and 246 with lung cancer (LC), 144 with colorectal cancer, 94 with gastric cancer, 115 with pancreatic cancer) were quantified simultaneously based on their respective calibration equations with correlation coefficient of >0.98.

Results: Receiver operating characteristic (ROC) analysis indicated that 18 panels obtained from these six phospholipids have high diagnostic ability to differentiate between different pathophysiological states. For example, a combination of SM(34:1), PC(34:2), PC(34:1), PC(36:3), and PC(36:2) to differentiating male patients with early stage LC from male normal controls plus male BLDs with a value under ROC curve (AUC) of 0.957, a sensitivity of 88.9%, and a specificity of 90.8%. SM(34:1) and PC(34:1) to differentiating female patients with early stage LC from female normal controls plus female BLDs with an AUC of 0.903, a sensitivity of 90.0%, and a specificity of 77.5%.

Conclusion: Change trends of these six phospholipids were significantly correlated with gender, physiological states, and cancer stages.

Keywords: phospholipids, lung cancer, colorectal cancer, gastric cancer, pancreatic cancer, CBDInanoESI-FTICR MS, early diagnosis.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Guo Y, Ren J, Li X, Liu X, Liu N, Wang Y, Li Z. Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreas. J Cancer 2017; 8(12):2191-2204. doi:10.7150/jca.19128. Available from http://www.jcancer.org/v08p2191.htm